MedPath
HSA Approval

B.S. TABLET

SIN00960P

B.S. TABLET

B.S. TABLET

May 10, 1988

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

J01EE01

sulfamethoxazole and trimethoprim

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

SULPHAMETHOXAZOLE

400 mg

Sulfamethoxazole

TRIMETHOPRIM

80 mg

Trimethoprim

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

B.S. TABLET - HSA Approval | MedPath